Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups ACW-135 and Y conjugate vaccineNimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups ACW-135 and Y conjugate vaccineInfanrix hexaPowder and suspension for suspension for injection. Diphtheria (D)tetanus (T)pertussis (acellularcomponent) (Pa)hepatitis B (rDNA) (HBV)poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed).Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNAcomponentadsorbed)Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups ACW-135 and Y conjugate vaccineInfanrix hexaPowder and suspension for suspension for injection. Diphtheria (D)tetanus (T)pertussis (acellularcomponent) (Pa)hepatitis B (rDNA) (HBV)poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed).ADX-038Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNAcomponentadsorbed)Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNAcomponentadsorbed)Infanrix hexaPowder and suspension for suspension for injection. Diphtheria (D)tetanus (T)pertussis (acellularcomponent) (Pa)hepatitis B (rDNA) (HBV)poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed).Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNAcomponentadsorbed)Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups ACW-135 and Y conjugate vaccinePrevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valentadsorbed)Infanrix hexaPowder and suspension for suspension for injection. Diphtheria (D)tetanus (T)pertussis (acellularcomponent) (Pa)hepatitis B (rDNA) (HBV)poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed).Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valentadsorbed)Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valentadsorbed)Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valentadsorbed)
Eligibility
Age group
65+ years, 18-64 years
Sex
Female, Male
Primary endpoint
Incidence and severity of TEAEs
Endpoint detail
1. Change from baseline in UPCR as measured by 24-hour urine over time, 2. Change from baseline in UPCR as measured by spot urine over time
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.